ADRA1D antibody (2nd Extracellular Domain)
Quick Overview for ADRA1D antibody (2nd Extracellular Domain) (ABIN1731576)
Target
See all ADRA1D AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- 2nd Extracellular Domain
-
Specificity
- Reacts with human ADRA1D
-
Cross-Reactivity (Details)
- BLAST analysis of the peptide immunogen showed no homology with other human proteins, except ADRA1B (56 % ).
-
Purification
- Antigen affinity purified
-
Immunogen
- Synthetic 18 amino acid peptide from 2nd extracellular domain of human ADRA1D. Percent identity with other species by BLAST analysis: Human (100%), Gorilla (100%), Monkey (100%), Marmoset (100%), Dog (100%), Panda (100%), Horse (100%), Pig (100%)
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Working dilution: IHC - P (2.5 μg/mL)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, Sodium azide 0.1 %
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C/-80 °C
-
Storage Comment
- Long term: -70°C, Short term: +4°C
-
-
- ADRA1D (Adrenergic Receptor, alpha 1d (ADRA1D))
-
Alternative Name
- ADRA1D
-
Background
- This alpha-adrenergic receptor mediates its effect through the influx of extracellular calcium.
-
UniProt
- P25100
Target
-